C3 and Alzheimer disease: Because complement C3 mediated mechanisms seem to play important roles in the clearance of circulating amyloid beta [32], the findings on lower plasma VLDL, IDL and LDL complement C3 levels in AD may suggest the role of plasma lipoprotein associated C3 in Aβ clearance via complement mechanisms.